RJA
SBRA icon

Raymond James & Associates’s Sabra Healthcare REIT SBRA Stock Holding History

Raymond James & Associates’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$391K Buy
+20,987
New +$354K ﹤0.01% 3251
2023
Q3 		– Sell
-13,908
Closed -$164K – 3927
2023
Q2 		$164K Sell
13,908
-53,455
-79% -$609K ﹤0.01% 3535
2023
Q1 		$775K Sell
67,363
-18,371
-21% -$227K ﹤0.01% 2628
2022
Q4 		$1.07M Buy
85,734
+14,428
+20% +$184K ﹤0.01% 2393
2022
Q3 		$936K Buy
71,306
+30,450
+75% +$450K ﹤0.01% 2437
2022
Q2 		$571K Sell
40,856
-5,205
-11% -$69.6K ﹤0.01% 2843
2022
Q1 		$686K Buy
46,061
+19,089
+71% +$261K ﹤0.01% 2863
2021
Q4 		$365K Sell
26,972
-8,318
-24% -$118K ﹤0.01% 3322
2021
Q3 		$519K Sell
35,290
-24,361
-41% -$411K ﹤0.01% 3038
2021
Q2 		$1.09M Buy
59,651
+6,087
+11% +$108K ﹤0.01% 2533
2021
Q1 		$930K Sell
53,564
-9,677
-15% -$170K ﹤0.01% 2563
2020
Q4 		$1.1M Sell
63,241
-40,355
-39% -$644K ﹤0.01% 2279
2020
Q3 		$1.43M Sell
103,596
-55,093
-35% -$809K ﹤0.01% 1964
2020
Q2 		$2.29M Buy
158,689
+12,084
+8% +$159K ﹤0.01% 1656
2020
Q1 		$1.6M Sell
146,605
-793,697
-84% -$14.6M ﹤0.01% 1705
2019
Q4 		$20.1M Sell
940,302
-5,148
-0.5% -$115K 0.03% 580
2019
Q3 		$21.7M Sell
945,450
-2,284
-0.2% -$48.7K 0.03% 512
2019
Q2 		$18.7M Sell
947,734
-322,241
-25% -$6.28M 0.03% 564
2019
Q1 		$24.7M Buy
1,269,975
+69,615
+6% +$1.32M 0.04% 453
2018
Q4 		$19.8M Sell
1,200,360
-144,187
-11% -$2.9M 0.03% 479
2018
Q3 		$31.1M Sell
1,344,547
-1,877
-0.1% -$42.5K 0.05% 371
2018
Q2 		$29.3M Buy
1,346,424
+215,954
+19% +$4.22M 0.05% 366
2018
Q1 		$20M Buy
1,130,470
+131,444
+13% +$2.32M 0.04% 476
2017
Q4 		$18.8M Sell
999,026
-56,856
-5% -$1.13M 0.03% 497
2017
Q3 		$23.2M Buy
1,055,882
+12,549
+1% +$284K 0.05% 390
2017
Q2 		$25.1M Buy
1,043,333
+304,038
+41% +$7.73M 0.05% 336
2017
Q1 		$20.6M Buy
739,295
+31,118
+4% +$816K 0.05% 386
2016
Q4 		$17.3M Sell
708,177
-14,254
-2% -$327K 0.04% 428
2016
Q3 		$18.2M Buy
722,431
+685,219
+1,841% +$16.4M 0.05% 370
2016
Q2 		$768K Buy
37,212
+4,827
+15% +$101K ﹤0.01% 1891
2016
Q1 		$651K Buy
32,385
+5,374
+20% +$103K ﹤0.01% 1908
2015
Q4 		$546K Buy
27,011
+12,896
+91% +$272K ﹤0.01% 1945
2015
Q3 		$327K Sell
14,115
-1,750
-11% -$44.7K ﹤0.01% 2102
2015
Q2 		$408K Sell
15,865
-3,480
-18% -$98.8K ﹤0.01% 2175
2015
Q1 		$641K Buy
19,345
+5,994
+45% +$195K ﹤0.01% 1914
2014
Q4 		$405K Sell
13,351
-27,495
-67% -$758K ﹤0.01% 2032
2014
Q3 		$993K Buy
+40,846
New +$1.13M 0.01% 1501

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Raymond James & Associates's SBRA Position: Q3 2024 in Review

Raymond James & Associates opened a new position in Sabra Healthcare REIT (SBRA) in Q3 2024: 20,987 shares worth $391K. The stake represents ﹤0.01% of the portfolio and ranks #3251 among its holdings. This is a return to the name: Raymond James & Associates previously reported a position in SBRA as recently as Q2 2023.

Raymond James & Associates first reported a position in SBRA in Q3 2014 and has held it in 37 quarters since. The position peaked at $31.1M in Q3 2018. 379 funds tracked by Wall St. Rank hold SBRA as of Q3 2024.

  • Raymond James & Associates held 20,987 shares of Sabra Healthcare REIT worth $391K as of Q3 2024.
  • Sabra Healthcare REIT was a new Raymond James & Associates position in Q3 2024.
  • Sabra Healthcare REIT made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3251 holding.
  • Raymond James & Associates first reported a position in Sabra Healthcare REIT in Q3 2014 and has held it in 37 quarters since.
  • Raymond James & Associates's Sabra Healthcare REIT position peaked at $31.1M in Q3 2018.
  • 379 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.